Efficacy of Trastuzumab + Cisplatin Combined with Irinotecan on the Quality of Life of Patients with Advanced Her-2 Positive Gastric Cancer

Figure 1

Comparison of the CA199 levels of the two groups of patients. Note: The abscissa represents before and after treatment, and the ordinate represents the expression level, mg/L; the expression levels of CA199 in the control group before and after treatment were 430.15 ± 54.18 and 255.94 ± 41.73; the expression levels of CA199 before and after treatment in the combination group were 427.88 ± 55.12 and 179.80 ± 36.15; indicating that the expression level of CA199 in the control group was significantly different before and after treatment (t = 19.732, ); indicates that the expression level of CA199 in the joint group before and after treatment was significantly different (t = 29.152, ); indicates that the CA199 expression level after treatment between the two groups was significantly different (t = 10.682, ).